Quantum Proteolysis Resulting from Release of Single Granules by Human Neutrophils: A Novel, Nonoxidative Mechanism of Extracellular Proteolytic Activity

Journal of Immunology

Volumn 157, Issue 6, 1996, Pages 2624-2631

  Liou, Theodore G ^a   Campbell, Edward J ^a,b,c  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXIDIZING AGENT; PROTEINASE; PROTEINASE INHIBITOR;

ARTICLE; CELL GRANULE; DOSE RESPONSE; HUMAN; METABOLISM; NEUTROPHIL; OXIDATION REDUCTION REACTION; SECRETION;

CYTOPLASMIC GRANULES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOPEPTIDASES; HUMANS; NEUTROPHILS; OXIDANTS; OXIDATION-REDUCTION; PROTEASE INHIBITORS;

EID: 0030587118     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Campbell, E. J., and M. A. Campbell. 1988. Pericellular proteolysis by neutrophils in the presence of proteinase inhibitors: effects of substrate opsonization. J. Cell Biol. 106:667.
2. Rice, W. G., and S. J. Weiss. 1990. Regulation of proteolysis at the neutrophil-substrate interface by secretory leukoprotease inhibitor. Science 249:178.
3. Owen, C. A., M. A. Campbell, P. L. Sannes, S. S. Boukedes, and E. J. Campbell. 1995. Cell-surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J. Cell Biol. 131:775.
4. Owen, C. A., M. A. Campbell, S. S. Boukedes, and E. J. Campbell. 1995. Inducible binding of cathepsin G to the cell surface of neutrophils: a mechanism for mediating extracellular proteolytic activity of cathepsin G. J. Immunol. 155:5803.
5. Ellis, V., T.-C. Wun, N. Behrendt, E. Rønne, and K. Danø. 1990. Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors. J. Biol. Chem. 265:9904.
6. Chen, W.-T. 1992. Membrane proteases: roles in tissue remodeling and tumour invasion. Curr. Opin. Cell Biol. 4:802.
7. Weiss, S. J. 1989. Tissue destruction by neutrophils. N. Engl. J. Med. 320:365.
8. Desrochers, P. E., and S. J. Weiss. 1988. Proteolytic inactivation of alpha-1-proteinase inhibitor by a neutrophil metalloproteinase. J. Clin. Invest. 81:1646.
9. 1-antitrypsin by metalloproteinases released from neutrophils. J. Clin. Invest. 82:706.
10. Desrochers, P. E., K. Mookhtiar, H. E. Van Wart, K. A. Hasty, and S. J. Weiss. 1992. Proteolytic inactivation of alpha 1-proteinase inhibitor and alpha 1-anti-chymotrypsin by oxidatively activated human neutrophil metalloproteinases. J. Biol. Chem. 267:5005.
11. Campbell, E. J. 1987. Letter to the editor. Am. Rev. Respir. Dis. 135:984.
12. Liou, T. G., and E. J. Campbell. 1995. Nonisotropic enzyme-inhibitor interactions: a novel non-oxidative mechanism for quantum proteolysis by human neutrophils. Biochemistry 34:16171.
13. Boyum, A. 1963. Isolation of mononuclear cells and granulocytes from human blood: isolation of mononuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. Invest. 21(Suppl. 97):77.
14. Stacey, D. W., and V. G. Allfrey. 1977. Evidence for the autophagy of micro-injected proteins in HeLa cells. J. Cell Biol. 75:807.
15. Forni, L. 1979. Reagents for immunofluorescence and their use for studying lymphoid cell products. In Immunological Methods. I. Lefkovits and B. Pernis, eds. Academic Press, New York, p. 151.
16. Williams, J. C., R. L. Stein, R. E. Giles, and R. D. Krell. 1991. Biochemistry and pharmacology of ICI 200,880, a synthetic peptide inhibitor of human neutrophil elastase. Ann. NY Acad. Sci. 624:257.
17. Thompson, R. C., and K. Ohlsson. 1986. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc. Natl. Acad. Sci. USA 83:6692.
18. 2-Macroglobulin. Methods Enzymol. 80:737.
19. Silverman, E. K., J. P. Miletich, J. A. Pierce, L. A. Sherman, S. K. Endicott, G. J. Broze, and E. J. Campbell. 1989. Alpha 1-antitrypsin deficiency: high prevalence in the St. Louis area determined by direct population screening. Am. Rev. Respir. Dis. 140:961.
20. 1-proteinase inhibitor in bronchoalveolar lavage fluids from healthy human smokers and non-smokers. Clin. Chim. Acta 132:309.
21. Martodam, R. R., R. J. Baugh, D. Y. Twumasi, and I. E. Liener. 1979. A rapid procedure for the large scale purification of elastase and cathepsin G from human sputum. Prep. Biochem. 9:15.
22. Powers, J. C., and B. F. Gupton. 1977. Reaction of serine proteases with aza-amino acid and aza-peptide derivatives. Methods Enzymol. 46:208.
23. 2-globulins of human serum. Clin. Chim. Acta 13:597.
24. Chase, T., and E. Shaw. 1967. p-Nitrophenyl-p′-guanidinobenzoate HCl: a new active site titrant for trypsin. Biochem. Biophys. Res. Commun. 29:508.
25. Platt, J. L., and A. F. Michael. 1983. Retardation of fading and enhancement of intensity of immunofluorescence by p-phenylenediamine. J. Histochem. Cytochem. 31:840.
26. Campbell, E. J., R. M. Senior, J. A. McDonald, and D. L. Cox. 1982. Proteolysis by neutrophils: relative importance of cell-substrate contact and oxidative inactivation of proteinase inhibitors in vitro. J. Clin. Invest. 70:845.
27. Quie, P. G., J. G. White, B. Holmes, and R. A. Good. 1967. In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J. Clin. Invest. 46.668.
28. Curnutte, J. T. 1993. Chronic granulomatous disease: the solving of a clinical riddle at the molecular level. Clin. Immunol. Immunopathol. 67:S2.
29. 1-antitrypsin phenotypes. Chest 100:703.
30. Ellis, G. W. 1979. A fiber-optic phase-randomizer for microscope illumination by laser. J. Cell Biol. 83:303a.
31. Ellis, G. W. 1985. Microscope illuminator with fiber optic source integrator. J. Cell Biol. 101:83a.
32. 1-proteinase inhibitor to protect lung elastin from elastolytic degradation. Hoppe-Seyler's Z. Physiol. Chem. 365:731.
33. Rao, N. V., B. C. Marshall, B. H. Gray, and J. R. Hoidal. 1993. Interaction of secretory leukocyte protease inhibitor with proteinase-3. Am. J. Respir. Cell Mol. Biol. 8:612.
34. Bieth, J. G. 1986. Elastases: catalytic and biological properties. In Biology of Extracellular Matrix: Regulation of Matrix Accumulation. R. P. Mecham, ed. Academic Press, Orlando, p. 217.
35. Campbell, E. J., E. K. Silverman, and M. A. Campbell. 1989. Elastase and cathepsin G of human monocytes: quantification of cellular content, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activity. J. Immunol. 143:2961.
36. Takahashi, H., T. Nukiwa, P. Basset, and R. G. Crystal. 1988. Myelomonocytic cell lineage expression of the neutrophil elastase gene. J. Biol. Chem. 263:2543.
37. Lungarella, G., R. Menegazzi, C. Gardi, P. Spessotto, M. Margherita de Santi, P. Bertoncin, P. Patriarca, P. Calzoni, and G. Zabucchi. 1992. Identification of elastase in human eosinophils: immunolocalization, isolation, and partial characterization. Arch. Biochem. Biophys. 292:128.
38. Meier, H. L., E. S. Schulman, L. W. Heck, D. MacGlashan, H. H. Newball, and A. P. Kaplan. 1989. Release of elastase from purified human lung mast cells and basophils. Inflammation 13:295.
39. Campbell, E. J. 1986. Preventive therapy of emphysema: Lessons from the elastase model. Am. Rev. Respir. Dis. 134:435.
40. Reddy, V. Y., P. E. Desrochers, S. V. Pizzo, S. L. Gonias, J. A. Sahakian, R. L. Levine, and S. J. Weiss. 1994. Oxidative dissociation of human alpha 2-macroglobulin tetramers into dysfunctional dimers. J. Biol. Chem. 269:4683.
41. Reddy, V. Y., S. V. Pizzo, and S. I. Weiss. 1989. Functional inactivation and structural disruption of human alpha 2-macroglobulin by neutrophils and eosinophils. J. Biol. Chem 264:13801.
42. Ohlsson, K., U. Fryksmark, and H. Tegner. 1980. The effect of cigarette smoke condensate on alpha-1-antitrypsin, antileukoprotease, and granulocyte elastase. Eur. J. Clin. Invest. 10:373.
43. Carp, H., and A. Janoff. 1980. Inactivation of bronchial mucous proteinase inhibitor by cigarette smoke and phagocyte-derived oxidants. Exp. Lung Res. 1:225.
44. Kramps, J. A., C. Van Twisk, E. C. Klasen, and J. H. Kijkman. 1988. Interactions among stimulated human polymorphonuclear leukocytes, released elastase and bronchial antileukoprotease. Clin. Sci. 75:53.
45. Henson, P. M., and R. B. Johnston, Jr. 1987. Tissue injury in inflammation: oxidants, proteinases, and cationic proteins. J. Clin. Invest. 79:669.
46. Janoff, A. 1985. Slate of the art: elastases and emphysema: current assessment of the protease-antiprotease hypothesis. Am. Rev. Respir. Dis. 132:417.
47. Wewers, M. 1989. Pathogenesis of emphysema: assessment of basic science concepts through clinical investigation. Chest 95:190.
48. Niewoehner, D. E. 1988. Cigarette smoking, lung inflammation, and the development of emphysema. J. Lab. Clin. Med. 111:15.
49. De Water, R., L. N. A. Willems, G. N. P. Van Muijen, C. Franken, J. A. M. Fransen, J. H. Dijkman, and J. A. Kramps. 1986. Ultrastructural localization of bronchial antileukoprotease in central and peripheral human airways by a gold-labeling technique using monoclonal antibodies. Am. Rev. Respir. Dis. 133:882.
50. Burkhardt, H., M. Kasten, and S. Rauls. 1987. Purification and characterization of a serine proteinase inhibitor from human articular cartilage. Biochim. Biophys. Acta 924:312.
51. Bohm, B., R. Deutzmann, and H. Burkhardt. 1991. Purification of a serine-proteinase inhibitor from human articular cartilage: identity with the acid-stable proteinase inhibitor of mucous secretions. Biochem. J. 274:269.
52. 1-antitrypsin to inhibit degradation of fibrinogen by adherent polymorphonuclear leukocytes from normal subjects and patients with chronic granulomatous disease. Am. J. Respir. Cell Mol. Biol. 6:521.
53. Llewellyn-Jones, C. G., D. A. Lomas, and R. A. Stockley. 1994. Potential role of recombinant secretory leucoprotease inhibitor in the prevention of neutrophil mediated matrix degradation. Thorax 49:567.
54. Kramps, J. A., A. H. Te Boekhorst, J. A. Fransen, L. A. Ginsel, and J. H. Dijkman. 1989. Antileukoprotease is associated with elastin fibers in the extracellular matrix of the human lung. Am. Rev. Respir. Dis. 140:471.
55. 1-antitrypsin deficiency. Acta Med. Scand. 175:197.
56. 1-antitrypsin as an inhibitor of neutrophil elastase. J. Clin. Invest. 80:1366.
57. Ossanna, P. J., S. T. Test, N. R. Matheson, S. Regiani, and S. Weiss. 1986. Oxidative regulation of neutrophil elastase-alpha-1-proteinase inhibitor interactions. J. Clin. Invest. 77:1939.